ProQR Therapeutics N.V. financial data

Symbol
PRQR on Nasdaq
Industry
Pharmaceutical Preparations
Location
Zernikedreef 9, Leiden, Netherlands
Fiscal year end
December 31
Former names
ProQR Therapeutics B.V. (to 10/3/2014)
Latest financial report
20-F - Q4 2023 - Mar 13, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 81.4M shares +0.67%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 25.1M EUR -50.6%
General And Administrative Expense 16.2M EUR -12.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 138M EUR -19.5%
Liabilities 96.5M EUR -7.79%